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A B S T R A C T
Most physicians regard left atrial appendage (LAA) thrombus as a contraindication for LAA occlusion due
to risk of distal embolization which is a serious complication. Here we report a case of successfully
implanted Amplazter cardiac plug without complication in elderly patients having LAA thrombus with
recurrent embolic events despite oral anticoagulants for prevention of thromboembolic events.
<Learning objective: LAA thrombus is not completely resolved in all cases and can be a potential source
of stroke or embolization even during anti-coagulation. We would like to share a case that suffered from
6 strokes or embolizations despite anti-coagulation, warfarin or non-vitamin K antagonist oral anti-
coagulants due to incomplete resolution of LAA thrombus. In this clinical situation, we can suggest LAA
occlusion to isolate thrombus from LA and prevent further stroke or embolization.>
© 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Journal of Cardiology Cases
jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ jcc as eIntroduction
Current guidelines recommend oral anticoagulation therapy for
stroke prevention in patients with nonvalvular atrial fibrillation
(AF) according to CHA2Ds2-VASc score and HAS-BLED score
[1]. Percutaneous left atrial appendage (LAA) closure is an
alternative treatment for permanent protection from thromboem-
bolism, avoiding lifelong antithrombotic therapy, and minimizing
the risk of bleeding.
Case report
A 74-year-old woman with persistent AF was referred for
percutaneous LAA closure due to recurrent thromboembolism
despite treatment with oral anticoagulants. She had suffered
from six embolic events of right cerebellar infarction and left
popliteal artery occlusion 3 years previously, left renal infarction
and left cerebellar infarction 1 year previously, and right distal
brachial artery occlusion and bilateral renal infarction 1 month
previously (Fig. 1). She took various oral anticoagulants including* Corresponding author at: Division of Cardiology, Severance Cardiovascular
Hospital, Yonsei University College of Medicine, 03722 Yonsei-ro 50-1, Seodaemun-
gu, Seoul, Republic of Korea. Fax: +82 2 393 2041.
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1878-5409/© 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rightswarfarin, ribaroxaban, and dabigatran which failed to prevent
recurrent embolism events. Echocardiography and cardiac
computed tomography revealed LAA thrombus (Fig. 2A and D).
After we had an in-depth discussion about the benefits and risks
with a surgeon, imaging specialist, the patient and her family
members in consideration of the patient’s condition and thrombus
location at distal part of LAA, we decided to perform carefully LAA
closure with no-touch technique to prevent dislodging the
thrombus within the LAA. In order to close the LAA without
directly contacting LAA thrombus, we performed a left atrial (LA)
angiography through the sheath within LA instead of a LAA
angiography (Data Supplement Movie 1 in the online version at
DOI: 10.1016/j.jccase.2017.05.002). Then, we made a ball with a
lobe of the device by retracting the sheath in front of LAA, which
can allow for better transesophageal echocardiography visualiza-
tion of the device position and prevent damage to the LAA when
the sheath was introduced into the LAA. Then, sheath with device
was pushed cautiously to the landing zone not to touch the LAA
thrombus under guidance of transesophageal echocardiography
(Fig. 2B and E). Finally, the lobe was deployed at position of landing
zone followed by deployment of the disc. We successfully deployed
an Amplazter Cardiac Plug of 26 mm size (St. Jude Medical, St. Paul,
MN, USA; Fig. 2C and F, and Data Supplement Movie 2 in the online
version at DOI: 10.1016/j.jccase.2017.05.002). The patient was
discharged 4 days after the procedure and has been event-free
with anticoagulation. reserved.
Fig. 1.
Recurrent cerebral and systemic embolic events despite oral anticoagulants. Computed tomography, magnetic resonance imaging, or angiographic images of right
cerebellar infarction (A), left popliteal artery occlusion (B), left renal infarction (C), left cerebellar infarction (D), right distal brachial artery occlusion (E), and
bilateral renal infarction (F) are shown.
Fig. 2.
Key images of procedure and left atrial appendage (LAA) thrombus. Because of LAA thrombus confirmed by pre-intervention echocardiography and cardiac CT
angiography (A and D, arrow: thrombus), we made a ball by retracting the sheath covering the device in front of LAA (B) and pushed the device into LAA cautiously
not to touch a thrombus under fluoroscopic and transesophageal echocardiography guidance (E). Optimal results were initially confirmed by angiography (F) and
then, final echocardiography also confirmed optimal position and no acute complication (C).
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The rationale for LAA closure is that non valvular AF predisposes
to LA thrombosis which was reported as an independent predictor
of stroke [2]. In patients with LA or LAA thrombus, the high annual
rates of embolic events has been reported up to 13.8% per year [3]
and thrombus is localized within the appendage in 90% of the cases
[4]. However, vitamin K antagonist (VKA) or non-VKA oral anti-
coagulants (NOAC) may fail to resolve the thrombus. There are
several reports with small study populations regarding a wide
range of resolution rates (16–90%) of intra-atrial thrombus after
treatment with VKAs and we have limited data from case reports of
treatment with NOACs for thrombus resolution [5]. Therefore,
percutaneous LAA closure is good alternative treatment for
permanent protection from thromboembolism in cases with
recurrent stroke or embolization despite adequate anti-coagula-
tion treatment. However, there is no consensus for patients with
LAA thrombus because the presence of LAA thrombus was
considered as a contraindication for percutaneous LAA closure
in previous randomized controlled trials. This successfully treated
case suggests that we keep in mind percutaneous LAA occlusion for
stroke prevention despite LAA thrombus.Conflict of interest
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